Soneil Guptha Md Facc Fesc Fccp Fica Mfpm Gfmd Email & Phone Number

St. George, Ut, Us

Greater London, England, United Kingdom

United States

San Diego County, California, United States

United States

Experienced Executive, Boards, Committee, working groups, task force memberEntrepreneurial contractor and corporate team leaderClinical Development, Medical Affairs, Education & Medical MarketingCardio-Metabolic Medicines and Therapeutics and device developer, Educationist, Academic, Researcher Strategic forward thinker, Analytic solution finder utilising facts/data experiences in decision making, Polished articulator, orator, communicator,Guide coach and mentor

United States

Founder Director of the Academy with Dr Allen (RIP) and Dr Silva. involved in original development, launch and continuing evaluation of the elearning offerings of the academy. Now Board Director and Advisor to the Executive Committee of the IFAPP-Academy

United States

Medical Monitor - Cardio vascular, Diabetes, Renal, Early phase and Rare diseases

Pennsylvania

I was responsible for end to end development expertise in Cardio-metabolic drug and device development, CV Imaging, CV Outcomes trials and Medical Affairs. This responsibility was serviced by consultation and leadership performance as internal KOL and to partnering clients in the industry academia regulators and educators.

Jaipur Area, India

Clinical cardiologist and Internist

Consultant to Industry, Reglatory agenies, Pharmacie, Hospitals and academics on Cardio-metabolic Clinical development, Medical Affairs and Medical Marketing

Singapore

Developed strategic positioning for Merck cardio-metabolic products in Asia pacific region. Lead and supported all medical/scientific and regulatory efforts Launched global clinical trials (1) and regional/national IISP (3) Presented to the regulatory agencies and pricing agencies in Asia PacificLead Regional Scientific Affairs Team and indirect supervisory responsibility of country lead physicians, research coordinators and regulatory officersMember of Global Medical Team, Global Commercial Team, Global Product teamsBudget responsibility of projects

New Jersey, Usa

Lead all Global Medical Affairs activities in Europe, Latin America, and Asia pacific including Japan based in HQ (Whitehouse Stn, NJ, USA) for Cozaar/Hyzaar, Zocor, Aggrastat, Cancidas Developed and completed 14 IISPs and two phase IV regulatory trial (LIIFE & HEAAL)Defended CZR/HZR at Bfarm in Germany and EMEAPublications in peer review journals (HEAAL, ON-TIME2, Asia-HEAALTH) and presentations in International conferences (3)Lead global medical team meetings and coached country lead physicians for therapeutic and operational excellenceBudget responsibility for all projects

Chicago, Illinois, Usa

Developed a department from scratchLicensed and developed life cycle program for (Corolopam)Direct supervisory responsibility of MDs, PharmD, Phds in departmentDeveloped and successfully completed protocols to support national and international life cycle managementAgreed with FDA and completed pediatric exclusivity (Corlopam)Completed and secured re-license (Abbokinase) Sales training, review of promotional reviewLead the global development teams for Corolopam, Abbokinase and ABT-578 Biocompatible/Endeavour programSupported commercial in- licensing activities (Orion Pharmaceuticals) and alliance management (Biocompatibles, Perclose) for CV projects & devicesSecured IDE for ABT-578 and launched Endeavor stent programDeveloped a portfolio of cardiovascular acquisition targets (Knoll) – Hirudin, Verapamil, Trandpril, Propafenone, and Endothelin Receptor AntagonistsProfit planning for the department and developmental programs

Sandwich Uk & Groton, Ct, Usa

Pitched successfully and developed International Clinical Research Group (India, China) under supervision of Sr VP Pfizer Clinical ResearchCo-Developed GCP guidelines with Chinese and Indian regulatory agencies and thought leadersStarted and successfully implemented Pfizer Pfellowship program in collaboration with Harvard Medical School and research operations in new theatresTeam member for due diligence activity for Lipitor Lead Phase IV study in hyperlipdemia (Lipitor) in US and international markets. Lead phase III studies in microalbuminuria and neuropathy (Aldose Reductase Inhibitor)Supervisory responsibility of in-house CRAs, outsourced CROsChaired international symposia and executive committees.Budgetary responsibility of lead projectsMember of early development management team for CV projects

London, England, United Kingdom

Honorary Attending Consulting Specialist in the Hospitals (twice a week) for outpatient care at the MRC Lipoprotein Clinic and BHF preventative cardiac clinic

Hoddesdon, Herts Uk

Scientific Leader for commercial development of Zocor and Innovace in UK and Eire, Successful submission and negotiations of subsequent labeling modifications (x3) with MCA/EMEA for Zocor and InnovaceDeveloped, lead and completed approx 54 clinical trialsSales training, promotional review of commercial materialsManaged (local candidate team leader) a team of physicians, CRAs, Biostatisticians and CROs to conduct the phase III program for Aggrastat, Singulair and Losartan in EUCo-chaired National and European symposia and executive committees Provided medical information and safety monitoring to regulatory agency, medical community, public affairs and marketing colleagues.

Various training positions leading to positions of responsibility in day to day care of the patients, teaching undergraduates and nursing students, supervising junior training staff and managing the interventional cath as well as out-patient noninvasive labs.Sub-investigator for Phase 4 studies in India and UKTeaching UG students and PG fellows and CME for allied health care professionals

Vauxhall, London Uk

Provided professional service (evaluation of safety efficacy and quality of medicines) to the Committee on Safety of Medicines and its sub-committeesLead responsibility of the yellow card scheme for continues safety assessment of cardio-respiratory products Lead Medical assessor (reviewer) post-marketing surveillance studies, Provided safety information to doctors and the pharmaceutical industry. Lead responsibility of medical scrutiny and assessment of patient information leaflets, pack inserts, drug promotion and labelingRepresented the Government (MCA) as lead expert witness on drug defect cases (6)Responded to questions from the Parliament (UK) on Drug safetyDeveloped the first draft of EMEA regulations for Pharmaco-vigilance and patient Information leaflets

Clinical cardiologist and Internist with ineterst in paharmacology and care of the elderly